Explore the words cloud of the INTUI-VIEW project. It provides you a very rough idea of what is the project "INTUI-VIEW" about.
The following table provides information about the project.
PHILIPS MEDICAL SYSTEMS NEDERLAND BV
|Coordinator Country||Netherlands [NL]|
|Total cost||3˙079˙660 €|
|EC max contribution||2˙361˙697 € (77%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2. (PRIORITY 'Industrial leadership')
|Duration (year-month-day)||from 2015-11-01 to 2018-10-31|
Take a look of project's partnership.
|1||PHILIPS MEDICAL SYSTEMS NEDERLAND BV||NL (BEST)||coordinator||905˙069.00|
|2||B. BRAUN MELSUNGEN AG||DE (MELSUNGEN)||participant||770˙175.00|
|3||OSLO UNIVERSITETSSYKEHUS HF||NO (OSLO)||participant||686˙453.00|
Developments in medical care are driven by increasing patient care quality and reducing cost. In the field of anaesthesia, the use of regional techniques has led to improved patient outcome and reduced costs compared to general anaesthesia. However, only 60% of anaesthesiologists perform peripheral nerve block procedures regularly. A wider adoption is hindered by lack of adequate technology. Currently they are largely navigating “in the blind”, using indirect measures as well as their anatomical experience to decide where they should inject. The INTUI-VIEW solution will change this. In the INTUI-VIEW project, Philips, B.Braun and Oslo University Hospital are partnering in order to bring an ultrasound tablet solution with needle tracking technology to the market. The solution is a revolutionary and new technique. It will speed up transition from general anesthesia to regional anesthesia. Patients will receive better, first time right regional anesthesia procedures, avoiding needle misplacements. The clinicians will receive a tool allowing them to do a safer, faster job with more predictable outcome. Finally, it will help hospital and health care systems to be more efficient by avoiding to waste expensive and limited resources. The scope of the project is to finalize the development of the INTUI-VIEW platform towards market introduction, industrialise and validate it in clinical settings, obtain regulatory approval and prepare market launch (2017). The two industrial partners are targeting a turnover of EUR 110 Mio in 2024, and a cumulative sales volume of EUR 700 Mio in 2024. Market adoption is expected to be 14% globally which translates into the treatment of 4.6 mln patients with INTUI-VIEW in 2024. In total, about 143 jobs will be created in both companies. In the R&D phase 30 FTE in Philips and 12 FTE in BBraun will be employed. After product launch 15 FTE in Philips (operations, service and support) and 86 FTE in B.Braun (production, marketing, sales).
Work performed, outcomes and results: advancements report(s)
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INTUI-VIEW" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "INTUI-VIEW" are provided by the European Opendata Portal: CORDIS opendata.
Tomographic 3D Ultrasound for Safe and More Cost Effective Vascular Diagnostics andTreatment PlanningRead More
Automatic non-destructive recognition of used printing techniques on substratesRead More
Market Uptake of Sustainable and Competitive Carbons for Energy StorageRead More